Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;22(1):92-100.
doi: 10.1007/s10995-017-2358-0.

Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies

Affiliations

Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies

Molly M Lynch et al. Matern Child Health J. 2018 Jan.

Abstract

Objective To explore women's perceptions of the risks and benefits associated with medication use during pregnancy and to better understand how women make decisions related to medication use in pregnancy. Methods We conducted online focus groups with 48 women who used medication during pregnancy or while planning a pregnancy, and 12 in-depth follow-up interviews with a subset of these women. Results We found that women were aware of general risks associated with medication use but were often unable to articulate specific negative outcomes. Women were concerned most about medications' impact on fetal development but were also concerned about how either continuing or discontinuing medication during pregnancy could affect their own health. Women indicated that if the risk of a given medication were unknown, they would not take that medication during pregnancy. Conclusion This formative research found that women face difficult decisions about medication use during pregnancy and need specific information to help them make decisions. Enhanced communication between patients and their providers regarding medication use would help address this need. We suggest that public health practitioners develop messages to (1) encourage, remind, and prompt women to proactively talk with their healthcare providers about the risks of taking, not taking, stopping, or altering the dosage of a medication while trying to become pregnant and/or while pregnant; and (2) encourage all women of childbearing age to ask their healthcare providers about medication use.

Keywords: Chronic disease; Medication; Preconception health; Pregnancy.

PubMed Disclaimer

References

    1. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2011 Aug 15;157(3):175–182. doi: 10.1002/ajmg.c.30313. - DOI - PubMed
    1. Baraka MA, Steurbaut S, Coomans D, Dupont AG. Ethnic differences in drug utilization pattern during pregnancy: A cross-sectional study. Journal of Maternal-Fetal & Neonatal Medicine. 2013 Jun;26(9):900–907. doi: 10.3109/14767058.2013.765843. - DOI - PubMed
    1. Bercaw J, Maheshwari B, Sangi-Haghpeykar H. The use during pregnancy of prescription, over-the-counter, and alternative medications among Hispanic women. Birth (Berkeley, Calif.) 2010 Sep;37(3):211–218. doi: 10.1111/j.1523-536X.2010.00408.x. - DOI - PubMed
    1. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 8. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
    1. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clinical Obstetrics and Gynecology. 2008 Mar;51(1):106–118. doi: 10.1097/GRF.0b013e318161d2c8. - DOI - PubMed

Publication types

LinkOut - more resources